Bullish Case: CWK at $13.115 has rebounded 8.7% off October's $12.06 low, call volume runs 75% above puts, and Helium's density concentrates highest mass near $12.50 (0.30-0.37) with $15 secondary support—consistent with mean reversion upward. German top-5 office take-up rose 18% YoY in Q3, India GCC expansion and flex-office growth (Bucharest sixfold) support services revenue. A quiet grind to $14-15 into Q4 earnings looks plausible.

Bearish Case: Term structure remains backwardated and deep-put IVs (130-345% at 5-10 strikes) still price genuine tail risk below $10; the SPY surface shows a widening left-tail cone out 300+ days, keeping macro transmission risk alive. CWK is down 16.5% YoY and -28% over five years, and the Helium forecast's -0.0 historical correlation means its +2.48% signal carries little empirical weight. The $52M bribery lawsuit naming CWK is an unquantified reputational/legal overhang.

Potential Outcomes: 1) 40%: Range $12.5-14 — Helium/market pdf peaks coincide at $12.50; falsifiable if price drifts outside for 5+ closes.
2) 25%: Push to $14.5-15.5 on Q4 earnings beat and call-flow dominance; testable by 15C IV falling below ~55% while delta rises.
3) 18%: Dip <$12 on macro/SPY left-tail shock or lawsuit headlines; re-steepening put skew confirms.
4) 10%: >$16 re-rating on strategic/M&A catalyst.
5) 7%: <$10 tail if risk-off accelerates.
Oracle: sell rich near-dated vega vs later-dated while $12.5 holds; invalidate on 3 closes <$12.

October 31, 2026